93 related articles for article (PubMed ID: 12917445)
1. Molecular determinants of the balance between co-repressor and co-activator recruitment to the retinoic acid receptor.
Benko S; Love JD; Beládi M; Schwabe JW; Nagy L
J Biol Chem; 2003 Oct; 278(44):43797-806. PubMed ID: 12917445
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
[TBL] [Abstract][Full Text] [Related]
3. Co-repressor release but not ligand binding is a prerequisite for transcription activation by human retinoid acid receptor alpha ligand-binding domain.
Kao HY; Han CC; Komar AA; Evans RM
J Biol Chem; 2003 Feb; 278(9):7366-73. PubMed ID: 12468549
[TBL] [Abstract][Full Text] [Related]
4. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids.
Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304
[TBL] [Abstract][Full Text] [Related]
5. Retinoid X receptor alpha (RXRalpha) helix 12 plays an inhibitory role in the recruitment of the p160 co-activators by unliganded RXRalpha/retinoic acid receptor alpha heterodimers.
Liu H; Shaw CK; Reineke EL; Liu Y; Kao HY
J Biol Chem; 2004 Oct; 279(43):45208-18. PubMed ID: 15310754
[TBL] [Abstract][Full Text] [Related]
6. Interactions that determine the assembly of a retinoid X receptor/corepressor complex.
Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046
[TBL] [Abstract][Full Text] [Related]
7. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.
Hörlein AJ; Näär AM; Heinzel T; Torchia J; Gloss B; Kurokawa R; Ryan A; Kamei Y; Söderström M; Glass CK
Nature; 1995 Oct; 377(6548):397-404. PubMed ID: 7566114
[TBL] [Abstract][Full Text] [Related]
8. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
9. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Germain P; Iyer J; Zechel C; Gronemeyer H
Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
[TBL] [Abstract][Full Text] [Related]
10. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.
le Maire A; Teyssier C; Erb C; Grimaldi M; Alvarez S; de Lera AR; Balaguer P; Gronemeyer H; Royer CA; Germain P; Bourguet W
Nat Struct Mol Biol; 2010 Jul; 17(7):801-7. PubMed ID: 20543827
[TBL] [Abstract][Full Text] [Related]
11. Critical role of tyrosine 277 in the ligand-binding and transactivating properties of retinoic acid receptor alpha.
Mailfait S; Belaiche D; Kouach M; Dallery N; Chavatte P; Formstecher P; Sablonnière B
Biochemistry; 2000 Mar; 39(9):2183-92. PubMed ID: 10694383
[TBL] [Abstract][Full Text] [Related]
12. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.
Wansa KD; Harris JM; Muscat GE
J Biol Chem; 2002 Sep; 277(36):33001-11. PubMed ID: 12082103
[TBL] [Abstract][Full Text] [Related]
13. Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma.
Kurebayashi S; Nakajima T; Kim SC; Chang CY; McDonnell DP; Renaud JP; Jetten AM
Biochem Biophys Res Commun; 2004 Mar; 315(4):919-27. PubMed ID: 14985100
[TBL] [Abstract][Full Text] [Related]
14. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
Pissios P; Tzameli I; Kushner P; Moore DD
Mol Cell; 2000 Aug; 6(2):245-53. PubMed ID: 10983973
[TBL] [Abstract][Full Text] [Related]
15. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
16. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain.
Flaig R; Greschik H; Peluso-Iltis C; Moras D
J Biol Chem; 2005 May; 280(19):19250-8. PubMed ID: 15716272
[TBL] [Abstract][Full Text] [Related]
18. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
Lausen J; Cho S; Liu S; Werner MH
J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
